THE FISSION YEAST FLCN/FNIP COMPLEX AUGMENTS TORC1 REPRESSION OR ACTIVATION IN RESPONSE TO AMINO ACID (AA) AVAILABILITY

The fission yeast FLCN/FNIP complex augments TORC1 repression or activation in response to amino acid (AA) availability

Summary: The target of Rapamycin complex1 (TORC1) senses and integrates several environmental signals, including amino acid (AA) availability, to regulate cell growth.Folliculin (FLCN) is a tumor suppressor (TS) protein in renal cell carcinoma, which paradoxically activates TORC1 in response to AA supplementation.Few tractable systems for modeling

read more

Update on the role of modified release mesalamine in the management of ulcerative colitis and Crohn’s disease

Glen A Doherty, Mark A PeppercornCenter for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston MA, USAAbstract: 5-aminosalicyclates (5-ASA) remain a key first-line therapy for patients with ulcerative colitis (UC).A range Horse Saddles of 5-ASA preparations is available and Eudragit-S® coated

read more